Does NATALIZUMAB Cause Cholelithiasis? 129 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Cholelithiasis have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.2% of all adverse event reports for NATALIZUMAB.
129
Reports of Cholelithiasis with NATALIZUMAB
0.2%
of all NATALIZUMAB reports
2
Deaths
101
Hospitalizations
How Dangerous Is Cholelithiasis From NATALIZUMAB?
Of the 129 reports, 2 (1.6%) resulted in death, 101 (78.3%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Cholelithiasis Listed in the Official Label?
Yes, Cholelithiasis is listed as a known adverse reaction in the official FDA drug label for NATALIZUMAB.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Cholelithiasis?
ADALIMUMAB (1,238)
OCTREOTIDE (641)
SEMAGLUTIDE (571)
METHOTREXATE (466)
TIRZEPATIDE (386)
PREDNISONE (346)
ETANERCEPT (345)
ACETAMINOPHEN (313)
LENALIDOMIDE (308)
CEFTRIAXONE (306)
Which NATALIZUMAB Alternatives Have Lower Cholelithiasis Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK